Biotechnology applications represent one of the most directly testable chapters in NEET Biology, consistently contributing 2–3 questions per year. This chapter bridges molecular biology tools (from BT-01) with their real-world deployment in medicine, agriculture, and industry.
Recombinant Insulin (Humulin)
Human insulin is synthesized as proinsulin, a single polypeptide that folds and undergoes post-translational cleavage to yield the functional hormone. The mature insulin consists of two chains: the A chain (21 amino acids) and the B chain (30 amino acids), connected by two inter-chain disulfide bonds and one intra-chain disulfide bond within the A chain. The C peptide, a connecting segment in proinsulin, is excised during processing and has no function in mature insulin.
In 1983, the American company Eli Lilly achieved a milestone by commercially producing recombinant human insulin. The genes encoding the A chain and B chain were separately inserted into E. coli plasmid vectors. Each chain was expressed independently in different E. coli cultures, purified, and then combined in vitro under oxidizing conditions to form proper disulfide bonds. This approach replaced insulin derived from pigs and cattle, which caused immune reactions in some diabetic patients due to minor structural differences from human insulin.
Gene Therapy and ADA Deficiency
Gene therapy involves delivering a functional copy of a defective gene into a patient's cells to correct the underlying genetic disorder. The first clinically approved gene therapy case involved ADA (adenosine deaminase) deficiency, a rare autosomal recessive disorder causing severe combined immunodeficiency (SCID). Without ADA, toxic deoxyadenosine accumulates and destroys T and B lymphocytes, leaving patients highly vulnerable to infections.
The therapeutic approach: peripheral lymphocytes are isolated from the patient, a functional ADA gene is introduced using a retroviral vector (retroviruses integrate stably into the host genome), and the corrected lymphocytes are returned to the patient by infusion. A key limitation is that mature lymphocytes are not self-renewing; the therapy must be repeated periodically. A permanent cure requires bone marrow transplantation (replacing the stem cells that generate all blood cells). PEG-ADA (pegylated ADA enzyme) is a pharmacological alternative, providing the missing enzyme externally.
Molecular Diagnostics
Three diagnostic technologies are central to NEET: PCR, ELISA, and autoradiography. PCR (Polymerase Chain Reaction) amplifies specific DNA sequences exponentially using thermostable Taq polymerase and sequence-specific primers. It is sensitive enough to detect a single copy of viral DNA, making it indispensable for early HIV diagnosis before antibody levels are detectable. PCR can also detect genetic mutations in carrier screening and prenatal diagnosis.
ELISA (Enzyme-Linked Immunosorbent Assay) detects the presence of either antigens or antibodies in a patient sample. An enzyme conjugated to a secondary antibody catalyzes a color-producing reaction — the intensity of color indicates the quantity of the target molecule. ELISA is used for HIV antibody detection, hepatitis B surface antigen testing, and pregnancy tests (detecting hCG). Autoradiography uses radioactively labeled probes (complementary nucleotide sequences) to detect specific DNA or RNA on nitrocellulose membranes after Southern or Northern blotting.
Bt Crops and the Cry Protein Mechanism
Bacillus thuringiensis (Bt) is a soil bacterium that produces crystalline insecticidal proteins encoded by cry genes. The critical fact: inside the living bacterium, Cry proteins exist as inactive crystalline protoxins. They are not toxic in this form. When an insect larva ingests the crystal, the alkaline pH of the insect's midgut (particularly lepidopteran larvae) solubilizes and cleaves the protoxin into an active Bt toxin. This active form binds to specific glycoprotein receptors on the midgut epithelial cell surface, inserts into the membrane, and creates large transmembrane pores. Ion imbalance, osmotic swelling, and cell lysis follow, killing the larva.
Gene-crop associations tested in NEET: Bt cotton carries cry1Ac and cry2Ab (both target cotton bollworm, Helicoverpa armigera, a lepidopteran). Bt corn carries cry1Ab (targets the European corn borer, Ostrinia nubilalis, also lepidopteran). Because both pests belong to Lepidoptera, the crops use Cry proteins of similar specificity but different receptor-binding domains.
RNA Interference (RNAi)
RNAi is a post-transcriptional gene-silencing mechanism triggered by double-stranded RNA (dsRNA). When dsRNA is introduced or produced inside a cell, the enzyme Dicer cleaves it into small interfering RNAs (siRNAs), which are incorporated into the RISC complex to degrade complementary mRNA. In the nematode control example: tobacco plants engineered to express both sense and antisense sequences of a nematode-essential gene produce complementary RNAs that anneal to form dsRNA inside the nematode Meloidogyne incognita, silencing essential nematode genes and preventing infection. This is a non-pesticide, species-specific approach.
Golden Rice and Flavr Savr Tomato
Golden Rice was developed by inserting genes for beta-carotene biosynthesis (from daffodil and a soil bacterium) into rice endosperm to address vitamin A deficiency, which causes blindness in children in developing countries. The rice endosperm naturally lacks the enzymes for the carotenoid pathway. The Flavr Savr tomato (approved by FDA in 1994) was the first commercially released GM food crop. It was engineered with an antisense copy of the polygalacturonase gene to reduce pectin degradation and delay softening, extending shelf life.
Transgenic Animals
Transgenic animals are created by introducing foreign genes into the germline. They serve four major purposes in biotechnology: (1) Bioreactor production — transgenic sheep produce alpha-1-antitrypsin in milk, used to treat hereditary emphysema; Rosie, the first transgenic cow, produced milk enriched with human alpha-lactalbumin for infant nutrition. (2) Disease models — transgenic mice carrying human oncogenes or Alzheimer's-related mutations enable drug development. (3) Vaccine safety testing — transgenic animals assess immune responses. (4) Chemical safety testing — transgenic animals replace conventional toxicity assays.
Biosafety, GEAC, and Biopiracy
India's regulatory framework for GMOs is managed by the Genetic Engineering Approval Committee (GEAC), which approves field trials and commercial release. Biosafety concerns include unintended gene flow (transgenes spreading to wild relatives), development of resistance in pests, and potential allergenicity of novel proteins.
Biopiracy is the unauthorized exploitation of biological resources or traditional knowledge without benefit-sharing. NEET-relevant cases: (1) Neem — a European company patented antifungal properties; patent challenged and revoked. (2) Turmeric — the University of Mississippi Medical Center patented turmeric's wound-healing use; India proved prior art (traditional use) and the patent was revoked. (3) Basmati rice — RiceTec Inc. (USA) obtained patents on basmati grain and plant traits; challenged by India, significant patent claims were cancelled.